EN DE
STOCK COMPARISON

GuangYuYuan Chinese Herbal Medicine Co vs Eli Lilly and: Fair Value & Quality

Both stocks run through our valuation models. Here is how GuangYuYuan Chinese Herbal Medicine Co (600771) and Eli Lilly and (LLY) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Eli Lilly and as the less overvalued of the two: GuangYuYuan Chinese Herbal Medicine Co trades at ¥14.29 versus a fair value of ¥2.83 (-80%), while Eli Lilly and trades at $1,186 versus $397 (-67%).
GuangYuYuan Chinese Herbal Medicine Co
600771.SHG · CNY · Health Care
-80%
upside to fair value
overvalued
Price¥14.29
Fair Value¥2.83
Quality70/100
Eli Lilly and
LLY · USD · Health Care
-67%
upside to fair value
overvalued
Price$1,186
Fair Value$397
Quality69/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

GuangYuYuan Chinese Herbal Medicine CoEli Lilly and
Valuation
102.1×P/E (TTM)42.2×
4.86×P/S (TTM)14.67×
4.28×P/B39.94×
42.1×EV/EBITDA30.2×
—PEG1.54×
—Dividend yield0.5%
—Dividend per share$6.23
Profitability
5%Net margin35%
15%Operating margin49%
4%Return on equity107%
3%Return on assets21%
Growth
17%Revenue growth (YoY)56%
6.6%Avg. growth/yr (3Y)31.7%
4.3%Avg. growth/yr (5Y)21.6%
Balance & size
0.12×Debt / equity1.54×
$1BMarket cap$1.1T
healthyGrowth qualitymixed

Eli Lilly and leads: 3 to 9 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

GuangYuYuan Chinese Herbal Medicine Coof which business quality 70 · market factors 35 Eli Lilly andof which business quality 65 · market factors 81
ProfitabilityMargins and returns on capital today
38
85
Quality GrowthAre margins and returns improving?
37
86
CashflowEarnings quality: real cash, not paper profit
80
51
Fin. StrengthBalance sheet, leverage, solvency risk
87
53
InvestmentDisciplined investing over empire-building
100
15
Low VolatilityCalm price path (market factor)
87
73
MomentumPrice trend over the last 3–12 months (market factor)
16
78
52W MomentumDistance to the 52-week high (market factor)
9
92
Net IssuanceBuybacks instead of dilution
89
93

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

GuangYuYuan Chinese Herbal Medicine Co

DCF Models¥5.66
Earnings-Based¥2.15
Dividend Discount¥0.04
Multiples¥3.36
Asset-Based¥2.23
Growth DCF¥6.72
Economic Profit¥2.62
Growth Earnings¥2.40

26 of 26 models see the stock below the current price.

Eli Lilly and

DCF Models$334
Earnings-Based$239
Dividend Discount$115
Multiples$358
Asset-Based$19.94
Growth DCF$187
Economic Profit$347
Growth Earnings$375

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

GuangYuYuan Chinese Herbal Medicine Co
Bear ¥2.13Fair Value ¥2.83Bull ¥3.54
¥14.29 = current price (white tick)
Eli Lilly and
Bear $222Fair Value $397Bull $582
$1,186 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

GuangYuYuan Chinese Herbal Medicine Co · Health Care

Quality score70 · Top 25%
Fair value upside-80% · bottom 25%

Eli Lilly and · Health Care

Quality score69 · Top 25%
Fair value upside-67% · bottom 25%

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Eli Lilly and as the less overvalued of the two: GuangYuYuan Chinese Herbal Medicine Co trades at ¥14.29 versus a fair value of ¥2.83 (-80%), while Eli Lilly and trades at $1,186 versus $397 (-67%).

GuangYuYuan Chinese Herbal Medicine Co has the higher quality score (70/100).

See the full analysis →
GuangYuYuan Chinese Herbal Medicine Co · Eli Lilly and

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to GuangYuYuan Chinese Herbal Medicine Co

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Eli Lilly and

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.